Czechia· CZ-0197870

XEOMIN

A botulinus toxin product containing botulinum toxin type a, free from complex proteins, registered in Czechia by Merz Pharmaceuticals GmbH, Frankfurt am Main. The same ATC class is registered in 11 of our 19 countries.

ATC M03AX01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedXEOMINATCM03AX01REGISTER NO.CZ-0197870PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Botulinus toxin is registered in 11 of 19 countries.

Countries holding a registration under ATC M03AX01 (botulinus toxin), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose

Botulinus toxin · ATC M03AX01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
BOTULINUM TOXIN TYPE A, FREE FROM COMPLEX PROTEINS
Manufacturer
Merz Pharmaceuticals GmbH, Frankfurt am Main
Country
Czechia (CZ)
ATC code
M03AX01
ATC class
Botulinus Toxin
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for botulinus toxin.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Botulinus toxin · interactions on record

55 records

  • 11 severe
  • 44 moderate

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • KanamycinA07AA08severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bc9ccf14-96e3-4d52-8acf-04f2d036b8dd
GET /v1/drugs/bc9ccf14-96e3-4d52-8acf-04f2d036b8dd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ PLV SOL",
  "source": "sukl",
  "strength": "100SU",
  "pack_size": "6X1",
  "substance": "BOTULINUM TOXIN TYPE A, FREE FROM COMPLEX PROTEINS",
  "cz_kod_sukl": "0197870",
  "product_type": "BI",
  "substance_codes": "18988",
  "registration_state": "R",
  "registration_number": "63/138/14-C"
}

See everything about botulinus toxin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.